WELLINGTON, New Zealand--Fisher & Paykel Healthcare Ltd. raised its full-year revenue and earnings forecasts as the coronavirus pandemic continues to significantly boost international sales of its hospital equipment.

The New Zealand-based company on Wednesday reported a half-year net profit of 225.5 million New Zealand dollars ($156.1 million), up 86% from a year earlier, driven by a near doubling in hospital revenue.

The higher profit reflected increased sales of the company's nasal airflow systems, Fisher & Paykel said. Hospitals have increasingly adopted "nasal high flow therapy" in treating patients sickened by Covid-19, it said.

The company said it now expects a full-year net profit of NZ$400 million to NZ$415 million, up from its previous forecast of NZ$365 million to NZ$385 million.

The forecast assumes that equipment sales to hospitals return to normal levels from January 2021.

It raised its full-year revenue forecast to NZ$1.72 billion from NZ$1.61 billion.

Write to Stephen Wright at stephen.wright@wsj.com

(END) Dow Jones Newswires

11-24-20 1612ET